Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.
about
Long term side effects of adjuvant chemotherapy in patients with early breast cancerPrevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsHow do chemotherapeutic agents damage the ovary?A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancerIncidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.Emerging gonadotropin-releasing hormone agonists.Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two casesMaintaining fertility in young women with breast cancer.Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors.A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.Breast cancer in young women: special considerations in multidisciplinary care.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patientsNCCN Task Force Report: Bone Health in Cancer Care.Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.Tamoxifen and ovarian function.Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.Postoperative endocrine therapy for invasive breast cancer.Fertility preservation and breast cancer: a reviewRandomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.Poor-prognosis estrogen receptor- positive disease: present and future clinical solutionsThe role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progreUnderstanding Fertility in Young Female Cancer Patients.Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamideChemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.The epidemiology of arm and hand swelling in premenopausal breast cancer survivorsMenses resumption after cancer treatment-induced amenorrhea occurs early or not at allCancer and fertility preservation: fertility preservation in breast cancer patients.Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levelsInsights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.Premature menopause in young breast cancer: effects on quality of life and treatment interventions.Fertility counseling of young breast cancer patients.Predictors of recovery of ovarian function during aromatase inhibitor therapy.Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.Breast cancer in young women and its impact on reproductive functionCharacterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.
P2860
Q28083233-FEE1CC26-EABC-48B9-A03A-EA6487AD4891Q28240178-55A600FF-A07C-49D3-80FF-5CF732635349Q28267696-75DC5A41-8E2E-409F-BCA2-8AD7B3B80AC6Q30435881-C35FD2B4-D960-49CC-97C7-CDD6A07C166EQ33601886-CDA905B4-1807-4C93-ABE0-B8DA25F0F301Q33630784-A677FCA7-4318-495D-B219-AFBEBFA233AFQ33796122-7E72F1BC-F146-49AA-826D-83937385E99EQ33838766-24CFEBED-2AA5-4BA8-81B2-701B50B5E9F1Q33939688-F7385A4D-8E50-49FE-9932-2D83DC2C78F0Q33967497-A4DD57D6-406E-4E1A-8076-DF117A156748Q34012451-06F893E3-B900-42FB-BF00-D80ED6AB841BQ34022790-F0B869AE-F2CE-4816-AFF5-1E668408462EQ34199333-D44873E3-59DE-49D6-9E28-24F352EF27EFQ34306522-CAB14F61-A953-4850-BD5E-D9B981B4BFCFQ34550633-8EBCD0AC-2B7E-4182-8917-5BF83955C080Q34617936-23FF7FC8-6E0B-43B7-9716-A6B8FCE1F099Q34709073-FFE0DD49-C35A-4CAC-A996-1926E8061F96Q34805784-7D1598D1-552A-49A0-8231-465C5D131759Q34877439-8815251A-ED86-4517-8106-EC283D216597Q34910095-0E269A51-3004-472B-A83E-9D7229E5F7E1Q35106163-27953007-0C70-48A0-90E0-3D112C578B00Q35808390-83833770-5E42-4E44-9BF8-F19EAD1881ABQ35949291-B9B4FE87-72D7-4D05-B30D-BB2BE966F4C4Q36022957-30526E55-8139-4E82-A3A2-840487E8F0C9Q36218039-EAACCE85-6E1A-422A-968A-95BFAA8D78BEQ36370462-41B23E6B-01B7-4639-943A-77CEC62616BCQ36405634-84CE5E79-4634-45B7-B076-B04419EF44ABQ36490058-E9387ACE-09BA-4066-8BAC-2C3263304AD1Q36630415-37C2DC15-1268-4D74-B302-C6CEA6BFB8C1Q36655965-44444589-2AA4-4DA7-B2B4-6B782DB25F6AQ36678693-D110FAF4-DD80-469F-B78C-AAE637C00962Q36691028-FDEE6FA3-AA55-423D-9504-6E3F53328FFEQ36885123-45038D02-4157-42FA-BC2A-5BAD58C7A2C8Q36950482-AB5B12A1-DAC1-4D0A-9720-82A5B519C02EQ36963345-1F989E37-77A0-46AE-8884-540C77E83C35Q36963384-53A6BE91-2C89-4BC6-8694-F3F0E4C4F85BQ37032856-502DF6C7-5CF2-4620-91F2-87AB85D0C108Q37127209-3DFAD2F8-3693-40C0-82C2-7FF2F196FA1CQ37153908-5719AD97-7220-46A2-989D-F7ED88F5D406Q37181877-404B003E-4797-49DA-9A7D-DD659648CA4F
P2860
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Incidence, time course, and de ...... reatment: a prospective study.
@en
Incidence, time course, and de ...... reatment: a prospective study.
@nl
type
label
Incidence, time course, and de ...... reatment: a prospective study.
@en
Incidence, time course, and de ...... reatment: a prospective study.
@nl
prefLabel
Incidence, time course, and de ...... reatment: a prospective study.
@en
Incidence, time course, and de ...... reatment: a prospective study.
@nl
P2093
P356
P1476
Incidence, time course, and de ...... reatment: a prospective study.
@en
P2093
Electra D Paskett
Elizabeth Z Naftalis
Jeanne A Petrek
L Douglas Case
Michelle J Naughton
Paniti Sukumvanich
S Eva Singletary
P304
P356
10.1200/JCO.2005.03.3969
P407
P577
2006-02-13T00:00:00Z